Page de couverture de S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

Visit http://morningcommutepodcast.com/SGLT2inhibitors5 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.

Ce que les auditeurs disent de S1E5 - SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.